Rectal or intramuscular diclofenac reduces the incidence of pancreatitis afterendoscopic retrograde cholangiopancreatography | Zendy

Ramazan Uçar | Zendy; Murat Bıyık | Zendy; Esma Uçar | Zendy; İlker Polat | Zendy; Sami Çifçi | Zendy; Hüseyin Ataseven | Zendy; Ali Rıza Demir | Zendy

Open Access

Rectal or intramuscular diclofenac reduces the incidence of pancreatitis afterendoscopic retrograde cholangiopancreatography

Author(s) -

Ramazan Uçar,

Murat Bıyık,

Esma Uçar,

İlker Polat,

Sami Çifçi,

Hüseyin Ataseven,

Ali Rıza Demir

Publication year - 2016

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-1502-104

Subject(s) - medicine , hyperamylasemia , diclofenac sodium , pancreatitis , endoscopic retrograde cholangiopancreatography , abdominal pain , acute pancreatitis , diclofenac , adverse effect , surgery , incidence (geometry) , randomized controlled trial , anesthesia , gastroenterology , amylase , biochemistry , chemistry , physics , optics , pharmacology , enzyme

Acute pancreatitis is the most common adverse event of endoscopic retrograde cholangiopancreatography (ERCP). We aimed to evaluate the efficacy of intramuscular diclofenac sodium for prophylaxis of post-ERCP pancreatitis (PEP) in comparison to the rectal form.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research